Journal of Radiation and Cancer Research

REVIEW ARTICLE
Year
: 2021  |  Volume : 12  |  Issue : 3  |  Page : 100--107

Preoperative radiotherapy and total neoadjuvant therapy in locally advanced rectal cancer management: So far, so good


Jyotiman Nath, Gautam Sarma 
 Department of Radiation Oncology, Dr B Borooah Cancer Institute, Guwahati, Assam, India

Correspondence Address:
Dr. Jyotiman Nath
Department of Radiation Oncology, Dr B Borooah Cancer Institute, Guwahati, Assam
India

The treatment outcomes of locally advanced rectal cancer (LARC) have significantly improved in the last few decades due to the continuous evolution of multimodality management. However, the distant failure remains a concern leading to more cancer-related deaths. Conventionally, preoperative chemoradiotherapy followed by total mesolectal excision and adjuvant chemotherapy is the standard of care for LARC patients. However, noncompliance to adjuvant chemotherapy due to various factors leads to more distant failure rates. As an alternative to this, multiple approaches of total neoadjuvant therapy (TNT) were investigated over time, and multiple reports have shown promising results. This review highlights the evolution of the multimodality management approach to LARC patients, emphasising preoperative radiotherapy and TNT.


How to cite this article:
Nath J, Sarma G. Preoperative radiotherapy and total neoadjuvant therapy in locally advanced rectal cancer management: So far, so good.J Radiat Cancer Res 2021;12:100-107


How to cite this URL:
Nath J, Sarma G. Preoperative radiotherapy and total neoadjuvant therapy in locally advanced rectal cancer management: So far, so good. J Radiat Cancer Res [serial online] 2021 [cited 2022 Jun 26 ];12:100-107
Available from: https://www.journalrcr.org/article.asp?issn=2588-9273;year=2021;volume=12;issue=3;spage=100;epage=107;aulast=Nath;type=0